Uterine artery embolization is emerging as a primary treatment for symptomatic uterine fibroids. This procedure is performed electively but occasionally is performed emergently in the setting of life-threatening hemorrhage. Most interventional radiologists performing this procedure use ultrasound or magnetic resonance imaging (MRI) for preprocedure evaluation and follow-up. Two case studies report the sonographic and color flow Doppler findings before, immediately after, and 3 months after uterine fibroid embolization (UFE) in an emergent UFE and an elective case. Angiographic and MRI correlation are also provided.
Case Study 1
A 37-year-old woman presented to the emergency room with a massive vaginal hemorrhage. Serum B-hCG was negative. Evaluation by a gynecologist revealed a large lower uterine mass. A stat ultrasound revealed a 7 cm hypoechoic posterior inferior uterine mass that was felt to be consistent with a fibroid (Fig. 1) . Color Doppler revealed the mass to be hypervascular (Fig. 2) . Even though the endometrium and its relationship to the fibroid were not well seen, it was thought to be submucosal in nature because of the symptomatic bleeding. A vaginal pack was positioned by the gynecologist, and the patient was started on premarin. The patient received 4 units of packed red blood cells, and the bleeding appeared to stop.
The patient was advised that a hysterectomy might be necessary if she rebled. She was not thought to be a candidate for a myomectomy. Interventional radiology was consulted, and the patient was a candidate for uterine fibroid embolization (UFE). She chose UFE, stating that she desired the chance for future pregnancy. The patient was advised that the effects of UFE on fertility are unknown but that she would be infertile if a hysterectomy was performed. As she was being prepared for the procedure, she rebled. Selective uterine artery angiograms revealed multiple hypervascular uterine masses consistent with fibroids. Active arterial extravasation into the uterine cavity was seen. Both uterine arteries were embolized with 500 to 700 micron polyvinyl alcohol (PVA) particles until complete stasis was achieved. Postembolization angiograms revealed disappearance of the abnormal vessels and cessation of active bleeding ( Figs. 3 and 4 ). An ultrasound performed within 24 hours after the procedure demonstrated a marked change in the appearance of the fibroids. There were speckled areas of focal increased echogenicity with complete absence of flow ( Fig. 5 ). Three months postprocedure, the patient has done well with no episodes of abnormal bleeding.
Case Study 2
A 49-year-old woman had a 10-year history of menorrhagia. She had undergone a myomectomy 12 years earlier and a cesarean section 11 years earlier. She suffered from bulk symptoms related to her fibroid uterus including urinary frequency, constipation, back pain, and pelvic pain. Magnetic resonance imaging (MRI) of the pelvis demonstrated an enlarged uterus with the large fibroid that distorted the endometrium (Fig. 6 ). Pelvic ultrasound examination showed an approximately 14 cm fibroid (Fig. 7) . The patient's Pap smear and endometrial biopsy were both normal. After reading extensively about UFE on the Internet, the patient strongly desired UFE instead of hysterectomy or myomectomy. The patient underwent an uneventful UFE, which embolized uterine arteries with PVA particles (Figs. 8 and 9 ). An ultrasound examination 24 hours post-UFE demonstrated speckle areas of increased echogenicity with absences of flow (Fig.  10A ). The patient had pain and low-grade fevers lasting 2 weeks. Her physical and laboratory values during this time were negative for infection, and it was thought that the fevers were part of a typical postembolization syndrome. At 3 months, the patient is symptom free. She is not experiencing any bulk-related symptoms. She has normal menstruation bleeding. Her 3-month follow-up MRI (Fig. 10B) and ultrasound (Fig. 10C) examinations show a marked decrease in size of the fibroid uterus.
Discussion
Uterine artery embolization has been a well-recognized and effective therapy for the treatment of acute pelvic hemorrhage. It has been used successfully in cases of postpartum hemorrhage, postsurgical bleeding, ectopic pregnancies, tumors, and vascular malformations. Uterine artery embolization for treatment of fibroids was first reported in 1995 by Ravina the first U.S. results for this procedure in 1997. Since that time, several thousand uterine artery embolization procedures have been performed worldwide as a definitive treatment for symptomatic fibroids. 3 The success of this procedure has been very encouraging, and patient satisfaction has been high. The results have included a greater than 90% success rate, which includes significant improvement in patients' abnormal uterine bleeding and relief of bulk-related symptoms and pelvic pain. There is an average 55% reduction in dominant fibroid volume and 40% reduction in total uterine volume at 3 months postprocedure. At 1 year postprocedure, there is an average 80% reduction in dominant fibroid volume and 58% reduction in total uterine volume. 4, 5 The procedure takes approximately 1 hour and involves performing pelvic angiography. A fibroid typically has one to two arteries supplying an internal vascular bed. There is generally not a collateral blood supply. Each uterine artery is selectively catheterized and then embolized with PVA particles. The PVA particles flow to the fibroids first because of the increased vascular demand in that region. The particles wedge in the vessels, cutting the blood supply to the fibroid. Once the blood supply is lost, the fibroids undergo infarction and necrosis. Normal myometrium has a rich collateral flow and is not infarcted by the procedure.
The patients are admitted overnight following the procedure. Patients may experience moderate to severe pain, nausea, and fever after the procedure for several days. Pain medications are prescribed to control these symptoms.
The complication rate including clinical failure, infection, diminished ovarian function, and uterine infarction necessitating hysterectomy has been extremely low. 5 For women who are not finished with childbearing, myomectomy remains the standard of care. The effects of UFE on subsequent pregnancy are unknown.
The sonographic findings after embolization correlate well with the expected outcome of the embolization procedure. The fibroids are devascularized, and there is no detectable blood flow with sensitized color Doppler imaging. As the fibroids infarct, the tissue releases nitrogen, forming small nitrogen bubbles in the infarcted fibroid (this is a well-known phenomenon seen in many embolization procedures). It is likely that the small echogenic foci seen in the fibroids postembolization are these small nitrogen bubbles. The fibroids also become much more visible and distinct from the surrounding myometrium postembolization because the original blood supply so well encapsulates the infarcted region. In the first case study, preembolization ultrasound revealed one fibroid, yet multiple fibroids were easily visualized postembolization. Presumably, this is due to the breakdown in the cellular structure of the infarcted fibroid, making its sonographic characteristics more distinctly different from normal myometrium than they are prior to infarction.
Later sonographic findings are similar to the known changes seen when a fibroid undergoes involution. The fibroids decrease in size and echogenicity, and will typically calcify. Careful follow-up scanning at 3 months and 1 year postembolization is often performed. This allows assessment of procedure success. A fibroid that continues to grow post-UFE is suspicious for anomalous blood supply not treated at the time of UFE, such as ovarian artery collaterals or possible sarcomatous degeneration. These fibroids require further investigation.
In summary, UFE represents a minimally invasive, nonsurgical alternative treatment for symptomatic uterine fibroids for women who do not want a myomectomy or a hysterectomy. When ultrasound is used for pre-and postprocedure evaluation, careful attention to and an understanding of the expected findings is necessary.
